rs113825926

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_004646.4(NPHS1):​c.881C>T​(p.Thr294Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,609,588 control chromosomes in the GnomAD database, including 138 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T294T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0083 ( 8 hom., cov: 32)
Exomes 𝑓: 0.011 ( 130 hom. )

Consequence

NPHS1
NM_004646.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.0780

Publications

9 publications found
Variant links:
Genes affected
NPHS1 (HGNC:7908): (NPHS1 adhesion molecule, nephrin) This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]
NPHS1 Gene-Disease associations (from GenCC):
  • congenital nephrotic syndrome, Finnish type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 3 uncertain in NM_004646.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0051461756).
BP6
Variant 19-35849107-G-A is Benign according to our data. Variant chr19-35849107-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00835 (1272/152352) while in subpopulation NFE AF = 0.0137 (930/68024). AF 95% confidence interval is 0.0129. There are 8 homozygotes in GnomAd4. There are 603 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHS1NM_004646.4 linkc.881C>T p.Thr294Ile missense_variant Exon 8 of 29 ENST00000378910.10 NP_004637.1 O60500-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHS1ENST00000378910.10 linkc.881C>T p.Thr294Ile missense_variant Exon 8 of 29 1 NM_004646.4 ENSP00000368190.4 O60500-1
NPHS1ENST00000353632.6 linkc.881C>T p.Thr294Ile missense_variant Exon 8 of 28 5 ENSP00000343634.5 O60500-2
NPHS1ENST00000592132.1 linkn.-113C>T upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00835
AC:
1271
AN:
152234
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00367
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00510
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00630
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0137
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00774
AC:
1897
AN:
245030
AF XY:
0.00803
show subpopulations
Gnomad AFR exome
AF:
0.00446
Gnomad AMR exome
AF:
0.00307
Gnomad ASJ exome
AF:
0.00110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00497
Gnomad NFE exome
AF:
0.0130
Gnomad OTH exome
AF:
0.00856
GnomAD4 exome
AF:
0.0112
AC:
16375
AN:
1457236
Hom.:
130
Cov.:
32
AF XY:
0.0112
AC XY:
8120
AN XY:
725134
show subpopulations
African (AFR)
AF:
0.00376
AC:
126
AN:
33472
American (AMR)
AF:
0.00331
AC:
148
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00393
AC:
339
AN:
86248
European-Finnish (FIN)
AF:
0.00697
AC:
341
AN:
48952
Middle Eastern (MID)
AF:
0.00475
AC:
27
AN:
5686
European-Non Finnish (NFE)
AF:
0.0134
AC:
14903
AN:
1111976
Other (OTH)
AF:
0.00766
AC:
462
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1099
2199
3298
4398
5497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00835
AC:
1272
AN:
152352
Hom.:
8
Cov.:
32
AF XY:
0.00809
AC XY:
603
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00368
AC:
153
AN:
41580
American (AMR)
AF:
0.00510
AC:
78
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4834
European-Finnish (FIN)
AF:
0.00630
AC:
67
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0137
AC:
930
AN:
68024
Other (OTH)
AF:
0.00662
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
67
133
200
266
333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0120
Hom.:
41
Bravo
AF:
0.00794
TwinsUK
AF:
0.0111
AC:
41
ALSPAC
AF:
0.0130
AC:
50
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.0119
AC:
102
ExAC
AF:
0.00871
AC:
1057
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0115
EpiControl
AF:
0.0117

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NPHS1: BP4, BS1, BS2 -

Sep 07, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15086927, 20507940, 11317351, 20981092, 26346198, 31216994) -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:3
Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis Benign:1
Jul 19, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Finnish congenital nephrotic syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital nephrotic syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.8
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.50
D;.
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.71
T;T
MetaRNN
Benign
0.0051
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.69
N;N
PhyloP100
0.078
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.071
Sift
Benign
0.060
T;D
Sift4G
Benign
0.28
T;T
Polyphen
0.097
B;.
Vest4
0.17
MVP
0.69
MPC
0.20
ClinPred
0.0023
T
GERP RS
-1.0
Varity_R
0.084
gMVP
0.43
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113825926; hg19: chr19-36340009; COSMIC: COSV62286333; COSMIC: COSV62286333; API